Decision: Favourable

Decisions Table

Study Title:

Phase 3 Randomized, Controlled Study of AAV5-hRKp.RPGR for the Treatment of X-linked Retinitis Pigmentosa Associated with Variants in the RPGR gene

  • NREC Code:

    22-NREC-CT-014

  • Decision:

    Favourable

  • Meeting Date:

    09/02/2022

  • Study Type:

    CT application

  • Principal Investigator:

    Professor David Keegan

  • PI Institution:

    UCD, MMUH

  • Sponsor:

    MeiraGTx UK II Ltd.

Scroll to Top